Super proud to announce our investment in MultivisionDx! Antler led MultivisionDX's €1M pre-seed round. We have been impressed by the potential of the diagnostic platform the team has developed and teams ability to share their vision and execute on the plan. The progress after the first discussions has been awesome. Really looking forward to continue to support the team in their journey. Congrats Michael Wittinger, Karolina, János L., Fabien Bertillot and Sara Wickström
MultivisionDx secures €1M in pre-seed funding! 🚀 This investment will accelerate the development of our spatial biology platform and transform personalized diagnostics to improve patient outcomes in the clinic. The funding round, led by Antler with significant contributions from Helsinki University Funds, Kaikarhenni and a Finnish angel investor, enables us to: 🔬 Expand and scale our spatial biology platform 🔬 Advance validation with leading cancer centers 🔬 Accelerate our path toward a diagnostic that truly benefits patients Our belief is simple: The next leap in precision medicine will come from providing an in-depth understanding of the tumor together with its microenvironment - spatially, quantitatively, and at scale. And we are building exactly that. As a team we are proud of this achievement, highly grateful for the trust of our investors, and excited for what’s next. Full story in the comments 👇
Thank you Antti Tormanen- we're hyped to be part of the Antler portfolio!